1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,

Slides:



Advertisements
Similar presentations
Where are we going « wrong »? Lack of coordination between the disciplines  Implication for the Patient – Not informed on the next steps – Not informed.
Advertisements

What is the most appropriate therapy for a 50 year old patient with T3N+ rectal cancer and isolated surgically resectable liver Metastases? – Systemic.
Neoadjuvant therapy for Rectal cancer
Informed Consent For Chemotherapy
Cornelis J.H. van de Velde, MD, PhD,FRCPS(hon)FACS(hon) Professor of Surgery President ECCO - the European Cancer Organization Past-President European.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
Rectal Cancer: A Complete Clinical Response…Now what?
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.
ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.
Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.
How to get more nodes in laparoscopic colon surgery John Marks MD Chief Division of Colorectal Surgery Lankenau Hospital and Institute of Medical Research.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
CRITICAL READING OF THE LITERATURE RELEVANT POINTS: - End points (including the one used for sample size) - Surrogate end points - Quality of the performed.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Dr. LP Si Tseung Kwan O Hospital. Introduction CA stomach is the 4 th most commonly diagnosed malignancy worldwide 2 nd most common cause of cancer-related.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
The Other Side of Health Care Costs: Is improved technology making a difference? Health care costs have increased dramatically over the past decade - largely.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Future Acute Care in Rural General Hospitals in Norway Professor Tor Ingebrigtsen CEO University Hospital of North Norway.
The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,
Capecitabine versus 5-fluorouracil-based (neo-)adjuvant chemo-radiotherapy for locally advanced rectal cancer: Long term results.
Finding N.E.M.O. Marvin R. Balaan, MD, FCCP System Division Director, Division of Pulmonary and Critical Care Medicine Allegheny Health Network, Pittsburgh.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
INTERNATIONAL CONFERENCE ON ADVANCED TREATMENT OF COLON CANCER Improving treatment of colon cancer. What is essential? JUNE BERGEN, NORWAY.
Role of EUS in colon lesions Pietro Fusaroli Gastroenterologia Università di Bologna.
Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise.
T4 Colon Cancer and Laparoscopic Approach Gustavo Plasencia MD FACS, FASCRS Clinical Professor of Surgery Gustavo Plasencia MD FACS, FASCRS Clinical Professor.
March 2001Management of Thyroid CancerInformation Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
Is surgical resection of an asymptomatic primary colorectal tumor beneficial for patients with incurable Stage IV disease? A Phase II Trial of 5-Fluorouracil,
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Delivering clinical research to make patients, and the NHS, better OG neoadjuvant therapy Brachytherapy Stephen Falk dd/mm/yyyy.
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.
Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.
Accuracy of EUS in diagnosis of rectal cancer KKUH experience
Adjuvant chemotherapy in Rectal Cancer?. What is the evidence for adjuvant chemotherapy? Do patients achieving a pathological complete response need chemotherapy?
Gastric Cancer Resections in BC: How are we doing? Trevor D Hamilton MD FRCSC Surgical Oncology Network November 7, 2015.
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Interesting case. OD yo man with irretrievable rectal TVA on screening colonoscopy, prior transanal excision 8 cm from anal verge Pmhx: hypothyroidism,
Senior Statistician Per-Henrik Zahl, MA MD PhD
National Oesophago–Gastric Cancer Audit  This slide set is designed to ◦Summarise the main audit findings for presentation at local MDT meetings.
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Specialist Breast Units – Does it improve Breast Cancer care? These Power Point presentations are free to download only for academic purposes, with due.
Using SEER-Medicare Data to Enhance Registry Data to Assess Quality of Care Joan Warren Applied Research Program National Cancer Institute NAACCR June.
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
Complete pathologic responses in the primary of rectal or colon cancer treated with FOLFOX without radiation A. Cercek, M. R. Weiser, K. A. Goodman, D.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Neoadjuvant chemotherapy in the treatment of NSCLC Department of Thoracic Oncology, University Hospital Ghent, Belgium Current Opinion in Oncology 2007,
Within the Cancer Program in MUH doing the best research and providing the best care to our patients. This is the best cancer care hospital.cancer care.
Oesophago–Gastric Cancer Audit
Laparoscopic surgery for rectal cancer What is the evidence?
National Oesophago–Gastric Cancer Audit 2015.
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Adjuvant Radiation is Required for Gastric Cancer
‘Improving Outcomes for people with skin tumours, including Melanoma’
Neoadjuvant Adjuvant Curative Palliative
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
Presentation transcript:

1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim, Norway

2 Contents Collection of data Incidence Outcomes Conclusions

3 Population trends 4.8 million, 12% increase in 25 yrs. 11% immigrants from > 200 countries Estimated population 2030; 5.8 million 20% > 65 yrs. Cancer in Norway 2008

4 Cancer Registry of Norway Cancer in Norway 2008

5 Collection of data National cancer registry since 1952 Compulsory reporting of all cancers and some precancrous lesions - all hospitals / health institutions - all physicians

6 Age adjusted incidence of colorectal cancer in the Nordic countries Nordcan

7 Colon cancer Rectal and anal cancer Cancer in Norway 2008

8 Colon cancer Rectal and anal cancer Cancer in Norway 2008

9 Interpretation Incidence of colon and rectal cancer have been increasing for decades, but the overall picture is one of stabilisation for colon cancer and possibly recent decline for rectal cancer Of particular note is the increasing survival and declining mortality for rectal cancer Among the likely determinants are the introduction of total mesorectal excision, increasing specialisation, and some use of preoperative chemoradiotherapy (20% 2004) Cancer in Norway 2008 Hansen M, Thesis 2010

10 Why has the relative survival for rectal cancer increased more in men than in women? Men 46% 62% Women57%67%

11 Is that because… the more difficult the dissection, the more benefit of an optimised surgical technique? for APR, more use of preop. radiotherapy? - 17% in men vs. 13% in women*, (mean age 71 vs. 73) for women, the relative survival was higher in the beginning, thus their potential for an increase will be less? * Hansen M, Thesis 2010

12 The Norwegian Colorectal Cancer Registry Database: records rectal cancer cases since colon cancer cases since 2007 Wibe, ECC 2010

13 Rectal cancer – pts. treated for cure: reduced local recurrence, increased survival, reduced complications 5-year local recurrence % % % % 5-year survival % % Anastomotic leaks % % Wibe et al. Colorectal Disease 2006; 8:

14 Variation in rate of local recurrence between hospitals Wibe et al. Colorectal Disease 2006; 8:

15 Due to variation of results treatment has been centralized 1994: 55 hospitals Recommended by the association of surgeons: ”rectal cancer surgery should only be performed by specialists in gastrointestinal surgery” 2000: 40 hospitals Dedicated colorectal surgeons treating rectal cancer 2004: 25 hospitals Healthcare bureaucracy introduced formal regulations: ”Only multidisciplinary teams of dedicated experts may treat rectal cancer”

16 What happened to hospitals having inferior results for rectal cancer, though continuing treatment?

17 Haugesund Central Hospital 5-yr local recurrence 5-yr overall survival % 48% % 70% % No local recurrence at Haugesund Central Hospital Best paper Norwegian Association of Surgeons 2008, Moen A C et al. abstract no 116

18 What did they do in Haugesund? How did they manage to improve that quickly?

Cylindric amputation Laparoscopic resection CT + Rectal ultrasound Oncologist Neoadjuvant tr.t acc. to guidelines Up-date radiologist GI oncologist Always GI surgeons MRI Multidiscpl. meetings Pathologist CT in follow-upNew retractors Stent as bridge to surgery Best paper Norwegian Association of Surgeons 2008, Moen A C et al. abstract no 116

20 They managed to improve within a few years,… because they focused on ”all the details”, i.e. important factors for quality assurance; - guidelines - training - competence - technology

21 Levanger hospital – 394 patients Patients treated with curative intent: Local recurrence5-yr survival % 65% % 58% % 71% p = Jullumstrø, Wibe, Lydersen, Edna. Thesis NTNU 2010

22 How could this happen?

23 That happened because… - they did not focus on quality assurance during the 90-ties - they did not stick to their optimised guidelines, they violated their own treatment protocol - neither they attended the national workshops, as everybody knew this staff could handle rectal cancer - in 2000 they started to attend the workshops Jullumstrø, Wibe, Lydersen, Edna. Thesis NTNU 2010

24 Recent initiatives by the Ministry of Health 2010: National guidelines on work-up, treatment and follow-up of colorectal cancer - developed by the Norwegian Gastrointestinal Cancer Group - revised once a year 2011: National guidelines on organisation of work-up and treatment of cancer, from receiving information on cancer: - 10 days for starting work-up - 20 days for starting treatment

25 Conclusion The incidence of colon cancer is still increasing, while rectal cancer has culminated Although the use of adjuvant chemotherapy for stage III colon cancer, the outcome of rectal cancer has exceeded that of colon cancer Most of the reduction of local recurrence and the increased survival for rectal cancer happened when preoperative radiochemotherapy was uncommon in Norway

26 Conclusion II Standards of care are best explained by healthcare structures and processes of care For complex medical treatment, the skills of the team of clinicians and the hospital organizational skill are equally important Quality assurance at different health care levels can only be evaluated within audits, during which underperforming departments are likely to improve Wibe et al. Br J Surg 2005;92:

27 Questions to be answered – from the organizer 1.Can we hope for similar results for colon as for rectal cancer? 2.Are there signs of such improvement? 3.What is the best approach on the road ahead? 1.But not that much, and not that fast, because the potential for improvement is less, but may be prof. Hohenberger has another view? 2. Yes, there is a steady and continuous tendency of increasing survival 3. The best approach is as always, focus on all the details, and MDT`s seem encouraging Yes, we can!

28